LGR5 and neoplasm: After tumor initiation, we found that the supplement of CAFs with LGR5+ tumor cells formed significantly larger tumors compared with engrafting LGR5+ cells alone (0.6 ± 0.2 vs. 0.3 ± 0.2 g, n = 5, p < 0.05, Figure 6B,C).